Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
Nexus Bedside provides a technology-enabled nursing care model that combines bedside and virtual nursing with AI support for hospitals, integrating real-time monitoring, communication, and EMR documentation. The service aims to improve patient outcomes, enhance staff safety, and reduce care costs while supporting the practice of bedside nursing.
0 investors
0 investors
ni2o is a US-based company developing AI and brain-computer interface (BCI) technology to detect and treat neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Its products span software for ultra-early detection, a wearable EEG-like headcap for monitoring and non-invasive stimulation, and a minimally invasive brain micro-implant.
0 investors
0 investors
NICE builds iceless cold and compression therapy devices, including a post-surgery/injury recovery system and a palm cooling device for athletes. Its products target medical recovery for orthopedic procedures and performance training for athletes.
0 investors
0 investors
Nielsen BioSciences develops biopharmaceutical products that assess or treat immune responses, including skin test antigens for Valley Fever and candida infections, and investigational therapeutics for HPV-related lesions.
0 investors
0 investors
0 investors
Nimbus Healthcare is a telehealth wellness platform offering personalized treatment programs including GLP-1 medical weight loss, hormone optimization, and hair restoration, with medications compounded in its Austin pharmacy and delivered to patients. It provides clinician-led care, async doctor visits, and GLP-1-complementary meal plans to consumers across a range of U.S. states.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.
0 investors
NK-One Therapeutics is a biotechnology company developing a first-in-class intrathecal molecular therapy (SP-SAP) that selectively disables NK-1 receptor pain-signaling neurons in the spine to treat refractory pain in end-stage cancer patients. The therapy is in a Phase 1 clinical trial and is also intended for veterinary use.
0 investors
NKore BioTherapeutics is a cellular-based biotherapeutics company developing an allogeneic immunotherapy platform based on a proprietary method of activating natural killer (NK) cells, called Supercharged NK (sNK) cells. Its lead therapy, NK101, targets solid and blood cancers in adult and pediatric patients, with human clinical trials planned in the United States beginning in 2027.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors